Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Endocrine
Erschienen in: Endocrine 1/2011

01.02.2011 | Original Article

GnRH secretion is inhibited by adiponectin through activation of AMP-activated protein kinase and extracellular signal-regulated kinase

verfasst von: Xiao-Bing Cheng, Jun-Ping Wen, Jun Yang, Ying Yang, Guang Ning, Xiao-Ying Li

Erschienen in: Endocrine | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Adipokines produced from adipose tissues participate in regulation of reproduction, energy homeostasis, food intake, and neuroendocrine function in the hypothalamus. We have previously reported that adiponectin significantly reduced GnRH secretion from GT1-7 hypothalamic GnRH neuron cells. In this study, we further investigated the inhibition of GnRH secretion by adiponectin in vivo and found that extracellular signal-regulated kinase (ERK) was inhibited and AMPK activated. Furthermore, we found that activated AMPK by adiponectin reduced ERK phosphorylation, which possibly impaired GnRH secretion in GT1-7 cells.
Literatur
1.
R.S. Ahima, J.S. Flier, Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11, 327–332 (2000)CrossRefPubMed
2.
T.S. Tsao, H.F. Lodish, J. Fruebis, ACRP30 a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol. 440, 213–221 (2002)CrossRefPubMed
3.
N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi, T. Kadowaki, Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6, 55–68 (2007)CrossRefPubMed
4.
T. Kadowaki, T. Yamauchi, Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439–451 (2005)CrossRefPubMed
5.
U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, T. Schulthess, J. Engel, M. Brownlee, P.E. Scherer, Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073–9085 (2003)CrossRefPubMed
6.
T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, T. Kadowaki, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762–769 (2003)CrossRefPubMed
7.
K. Kos, A.L. Harte, N.F. da Silva, A. Tonchev, G. Chaldakov, S. James, D.R. Snead, B. Hoggart, J.P. O’Hare, P.G. McTernan, S. Kumar, Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J. Clin. Endocrinol. Metab. 92, 1129–1136 (2007)CrossRefPubMed
8.
M. Fry, P.M. Smith, T.D. Hoyda, M. Duncan, R.S. Ahima, K.A. Sharkey, A.V. Ferguson, Area postrema neurons are modulated by the adipocyte hormone adiponectin. J. Neurosci. 26, 9695–9702 (2006)CrossRefPubMed
9.
F. Rodriguez-Pacheco, A.J. Martinez-Fuentes, S. Tovar, L. Pinilla, M. Tena-Sempere, C. Dieguez, J.P. Castano, M.M. Malagon, Regulation of pituitary cell function by adiponectin. Endocrinology 148, 401–410 (2007)CrossRefPubMed
10.
J.P. Wen, W.S. Lv, J. Yang, A.F. Nie, X.B. Cheng, Y. Yang, Y. Ge, X.Y. Li, G. Ning, Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem. Biophys. Res. Commun. 371, 756–761 (2008)CrossRefPubMed
11.
E. Guillod-Maximin, A.F. Roy, C.M. Vacher, A. Aubourg, V. Bailleux, A. Lorsignol, L. Penicaud, M. Parquet, M. Taouis, Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J. Endocrinol. 200(1), 93–105 (2009)CrossRefPubMed
12.
Y. Qi, N. Takahashi, S.M. Hileman, H.R. Patel, A.H. Berg, U.B. Pajvani, P.E. Scherer, R.S. Ahima, Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524–529 (2004)CrossRefPubMed
13.
M. Lu, Q. Tang, J.M. Olefsky, P.L. Mellon, N.J. Webster, Adiponectin activates AMPK and decreases luteinizing hormone secretion in L{beta}T2 gonadotropes. Mol. Endocrinol. 22, 760–771 (2008)CrossRefPubMed
14.
A. Bottner, J. Kratzsch, G. Muller, T.M. Kapellen, S. Bluher, E. Keller, M. Bluher, W. Kiess, Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 89, 4053–4061 (2004)CrossRefPubMed
15.
F. Lanfranco, M. Zitzmann, M. Simoni, E. Nieschlag, Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin. Endocrinol. (Oxf.) 60, 500–507 (2004)CrossRef
16.
D. Modan-Moses, D. Stein, C. Pariente, A. Yaroslavsky, A. Ram, M. Faigin, R. Loewenthal, E. Yissachar, R. Hemi, H. Kanety, Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J. Clin. Endocrinol. Metab. 92, 1843–1847 (2007)CrossRefPubMed
17.
C.A. Stackpole, I.J. Clarke, K.M. Breen, A.I. Turner, F.J. Karsch, A.J. Tilbrook, Sex difference in the suppressive effect of cortisol on pulsatile secretion of luteinizing hormone in sheep. Endocrinology 147, 5921–5931 (2006)CrossRefPubMed
18.
F.J. Karsch, J.T. Cummins, G.B. Thomas, I.J. Clarke, Steroid feedback inhibition of pulsatile secretion of gonadotropin-releasing hormone in the ewe. Biol. Reprod. 36, 1207–1218 (1987)CrossRefPubMed
19.
A.C. Gore, G. Yeung, J.H. Morrison, T. Oung, Neuroendocrine aging in the female rat: the changing relationship of hypothalamic gonadotropin-releasing hormone neurons and N-methyl-D-aspartate receptors. Endocrinology 141, 4757–4767 (2000)CrossRefPubMed
20.
I. Merchenthaler, T. Gorcs, G. Setalo, P. Petrusz, B. Flerko, Gonadotropin-releasing hormone (GnRH) neurons and pathways in the rat brain. Cell Tissue Res. 237, 15–29 (1984)CrossRefPubMed
21.
H. Ebinuma, T. Miida, T. Yamauchi, Y. Hada, K. Hara, N. Kubota, T. Kadowaki, Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin. Chem. 53, 1541–1544 (2007)CrossRefPubMed
22.
P.L. Mellon, J.J. Windle, P.C. Goldsmith, C.A. Padula, J.L. Roberts, R.I. Weiner, Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5, 1–10 (1990)CrossRefPubMed
23.
Y. Yang, L.B. Zhou, S.Q. Liu, J.F. Tang, F.Y. Li, R.Y. Li, H.D. Song, M.D. Chen, Expression of feeding-related peptide receptors mRNA in GT1-7 cell line and roles of leptin and orexins in control of GnRH secretion. Acta Pharmacol. Sin. 26, 976–981 (2005)CrossRefPubMed
24.
B. Kola, M. Boscaro, G.A. Rutter, A.B. Grossman, M. Korbonits, Expanding role of AMPK in endocrinology. Trends Endocrinol. Metab. 17, 205–215 (2006)CrossRefPubMed
25.
R.B. Ceddia, R. Somwar, A. Maida, X. Fang, G. Bikopoulos, G. Sweeney, Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48, 132–139 (2005)CrossRefPubMed
26.
X. Wu, H. Motoshima, K. Mahadev, T.J. Stalker, R. Scalia, B.J. Goldstein, Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355–1363 (2003)CrossRefPubMed
27.
T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, T. Kadowaki, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288–1295 (2002)CrossRefPubMed
28.
S. Coyral-Castel, L. Tosca, G. Ferreira, E. Jeanpierre, C. Rame, D. Lomet, A. Caraty, P. Monget, C. Chabrolle, J. Dupont, The effect of AMPK activation on GnRH secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats. J. Neuroendocrinol. 20(3), 335–346 (2008)CrossRefPubMed
29.
J. Kim, M.Y. Yoon, S.L. Choi, I. Kang, S.S. Kim, Y.S. Kim, Y.K. Choi, J. Ha, Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway. J. Biol. Chem. 276, 19102–19110 (2001)CrossRefPubMed
30.
R. Shibata, N. Ouchi, M. Ito, S. Kihara, I. Shiojima, D.R. Pimentel, M. Kumada, K. Sato, S. Schiekofer, K. Ohashi, T. Funahashi, W.S. Colucci, K. Walsh, Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10, 1384–1389 (2004)CrossRefPubMed
31.
H.J. Schaeffer, M.J. Weber, Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435–2444 (1999)PubMed
32.
R. Sasson, R.K. Dearth, R.S. White, P.E. Chappell, P.L. Mellon, Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons. Neuroendocrinology 84, 353–363 (2006)CrossRefPubMed
33.
A.B. Sprenkle, S.P. Davies, D. Carling, D.G. Hardie, T.W. Sturgill, Identification of Raf-1 Ser621 kinase activity from NIH 3T3 cells as AMP-activated protein kinase. FEBS Lett. 403, 254–258 (1997)CrossRefPubMed
Metadaten
Titel
GnRH secretion is inhibited by adiponectin through activation of AMP-activated protein kinase and extracellular signal-regulated kinase
verfasst von
Xiao-Bing Cheng
Jun-Ping Wen
Jun Yang
Ying Yang
Guang Ning
Xiao-Ying Li
Publikationsdatum
01.02.2011
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2011
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-010-9375-8

Weitere Artikel der Ausgabe 1/2011

Endocrine 1/2011 Zur Ausgabe

Original Article

In vitro functionality of isolated embryonic hypothalamic vasopressinergic and oxytocinergic neurons: modulatory effects of brain-derived neurotrophic factor and angiotensin II

Original Article

Gonadal steroids modulate Fas-induced apoptosis of lactotropes and somatotropes

Original Article

Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism

OriginalPaper

Diagnostic value of elastosonographically determined strain index in the differential diagnosis of benign and malignant thyroid nodules

Original Article

Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies

Original Article

Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise